Cite
MLA Citation
L Kahl et al.. “Safety, tolerability, efficacy and pharmacodynamics of the selective JAK1 inhibitor GSK2586184 in patients with systemic lupus erythematosus.” Lupus, vol. 25, 2016, pp. 1420–1430. http://access.bl.uk/ark:/81055/vdc_100067462708.0x000003